How Much Did Optain Raise?
Funding & Key Investors

Optain has successfully secured a significant capital injection, marking a pivotal moment in its corporate evolution. With a total cumulative backing of $38M, the firm has demonstrated robust market traction. The most recent financing round, which contributed $26M to the company balance sheet, underscores investor confidence in the firm's proprietary diagnostic technology and its potential to disrupt the global healthcare landscape.

What is Optain?

Optain
ManufacturingMedical Devices & EquipmentHealthcare Software

Optain Health operates at the intersection of artificial intelligence and ophthalmology, positioning itself as a leader in AI-driven retinal imaging. By leveraging sophisticated machine learning algorithms, the company provides a scalable platform for the early detection of ocular and systemic pathologies. This technological infrastructure is designed to integrate seamlessly into clinical workflows, effectively bridging the gap between complex diagnostic data and actionable medical insights. As a key player in the medical technology sector, Optain is redefining preventative care standards through high-fidelity imaging analysis.

How much funding has Optain raised?

Optain has raised a total of $38M across 2 funding rounds:

2023

Angel/Seed

$12M

2025

Series A

$26M

Angel/Seed (2023): $12M, investors not publicly disclosed

Series A (2025): $26M led by Insight Partners

Key Investors in Optain

Insight Partners

Insight Partners is a global venture capital and private equity firm that invests in high-growth software and technology companies. It provides capital and hands-on operational support to help businesses scale from early stage to IPO, focusing on enterprise software, SaaS, and internet platforms.

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Optain?

Following this major strategic investment, Optain is well-positioned to accelerate its commercial expansion and deepen its research and development capabilities. The current lifecycle stage, characterized by a transition from initial development to enterprise-level scaling, suggests a focus on market penetration and the refinement of its diagnostic algorithms. Future growth will likely center on expanding clinical partnerships and navigating regulatory pathways to broaden the application of its retinal imaging solutions. By prioritizing operational excellence and technological innovation, Optain aims to solidify its footprint in the competitive health-tech ecosystem, ensuring long-term value creation for stakeholders and improved patient outcomes.

See full Optain company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Building MaterialsManufacturingAutomotive PartsReal Estate
Industrial Machinery & EquipmentManufacturing
ManufacturingPlastic, Packaging & Containers
Industrial Machinery & EquipmentManufacturing

Frequently Asked Questions Regarding Optain Financial Insights

What are the most recent funding rounds that Optain has completed, and what were the funding rounds?
Optain has recently completed 2 funding rounds: Series A on Sep 10, 2025, Angel/Seed on May 9, 2023.
What is the total amount of funding Optain has raised to date?
Optain has raised a total of $38M in funding to date.
How many funding rounds has Optain completed?
Optain has completed 2 funding rounds.
How much funding did Optain raise in its most recent funding round?
Optain raised $26M in its most recent funding round.
Who are the lead investors in Optain's latest funding round?
The lead investor in Optain's latest funding round was Insight Partners. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Optain's history?
The largest funding round in Optain's history was $26M.
See more information about Optain